Background <p>Pneumonia remains a major cause of morbidity and mortality in elderly adults in India. Diabetes is strongly associated with pneumonia. Knowledge on pneumococcal vaccine (PV) among the physicians who treat diabetes (diabetologists) may impact their recommendations for individuals with diabetes and pneumonia comorbidity.</p> Objective <p>This study was conducted to assess the knowledge, attitude, and practice of pneumococcal vaccines among the diabetologists in India.</p> Methods <p>A quasi-experimental study was conducted online among the diabetologists across India from Sep 2023 to Feb 2024. An education session on the importance of PV in people with diabetes was given to the diabetologists region-wise (North = 23, Northeast = 26, West = 25, and South = 34). A pre- and post-education assessment was done using a semi-structured questionnaire which included knowledge, practice, and barriers in recommending PV.</p> Results <p>The knowledge improvement on PV was evident in all four regions: North (pre- vs. post-education: 7.5 ± 1.7 vs. 8.4 ± 1.6, <i>p</i> = 0.003), Northeast (6.6 ± 1.8 vs. 9.1 ± 2.0, <i>p</i> &lt; 0.001), West (7.2 ± 1.4 vs. 9.5 ± 1.6, <i>p</i> &lt; 0.001), and South (7.1 ± 1.5 vs. 8.9 ± 1.2, <i>p</i> &lt; 0.001). The average of correct responses increased by 17.4% (63.5 to 80.9%) after the education&#xa0;session. There was a significant difference in the average pre-education&#xa0;knowledge score on PV between the participants with &lt; 10 and ≥ 10 years of professional experience (6.6 ± 1.7 vs.7.4 ± 1.5, <i>p</i> = 0.021). But the knowledge score significantly improved after the session in those with &lt; 10 years of experience. Vaccine cost was noted as an important barrier in recommending and accepting PV.</p> Conclusion <p>Knowledge on PV was significantly improved among diabetologists post-education session. Affordable vaccine, vaccine education to the physicians and patients, and universalization of adult immunization may increase the recommendation and uptake of the vaccine.</p>

错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

Assessment of knowledge, facilitators, and barriers of pneumococcal vaccination: A quasi-experimental study among diabetologists in India

  • Arutselvi Devarajan,
  • Basab Ghosh,
  • Muralidharan Chakkarai,
  • Ajoy Tiwari,
  • Purvi Chawla,
  • Hemanga Barman,
  • Vijay Viswanathan

摘要

Background

Pneumonia remains a major cause of morbidity and mortality in elderly adults in India. Diabetes is strongly associated with pneumonia. Knowledge on pneumococcal vaccine (PV) among the physicians who treat diabetes (diabetologists) may impact their recommendations for individuals with diabetes and pneumonia comorbidity.

Objective

This study was conducted to assess the knowledge, attitude, and practice of pneumococcal vaccines among the diabetologists in India.

Methods

A quasi-experimental study was conducted online among the diabetologists across India from Sep 2023 to Feb 2024. An education session on the importance of PV in people with diabetes was given to the diabetologists region-wise (North = 23, Northeast = 26, West = 25, and South = 34). A pre- and post-education assessment was done using a semi-structured questionnaire which included knowledge, practice, and barriers in recommending PV.

Results

The knowledge improvement on PV was evident in all four regions: North (pre- vs. post-education: 7.5 ± 1.7 vs. 8.4 ± 1.6, p = 0.003), Northeast (6.6 ± 1.8 vs. 9.1 ± 2.0, p < 0.001), West (7.2 ± 1.4 vs. 9.5 ± 1.6, p < 0.001), and South (7.1 ± 1.5 vs. 8.9 ± 1.2, p < 0.001). The average of correct responses increased by 17.4% (63.5 to 80.9%) after the education session. There was a significant difference in the average pre-education knowledge score on PV between the participants with < 10 and ≥ 10 years of professional experience (6.6 ± 1.7 vs.7.4 ± 1.5, p = 0.021). But the knowledge score significantly improved after the session in those with < 10 years of experience. Vaccine cost was noted as an important barrier in recommending and accepting PV.

Conclusion

Knowledge on PV was significantly improved among diabetologists post-education session. Affordable vaccine, vaccine education to the physicians and patients, and universalization of adult immunization may increase the recommendation and uptake of the vaccine.